domingo, 27 de noviembre de 2016

Polymorphisms in FCGR3A and Degree of Trastuzumab Benefit | Breast Cancer | JAMA Oncology | The JAMA Network

Polymorphisms in FCGR3A and Degree of Trastuzumab Benefit | Breast Cancer | JAMA Oncology | The JAMA Network
November 03, 2016

Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast CancerAnalysis of the NSABP B-31 Trial

JAMA Oncol. Published online November 3, 2016. doi:10.1001/jamaoncol.2016.4884

Public Health Genomics Knowledge Base (v1.2)
Genomics & Health Impact Update banner with DNA in background



Last Updated: Nov 16, 2016
CDC Resources with and image of DNA
Seletced Insights & Reviews with various images of researchers in labortory environments
Epidemiology with an image of a crowd of people with a double helix
Translational Research with two images of people talking to a genetic counselor and an image of a hand with wrapped sequecing around it
Evidence Synthesis with an image of sequencing and a double helix
Practice & Implementation with images of people taking to a doctor and a nurse examining a child


Relevant Resources

No hay comentarios:

Publicar un comentario en la entrada